Daniel Lee is a Neurology physician. ClinicalTrials.gov lists 15 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
245 Flemingsburg Rd
Morehead, KY 403511015
Telephone
606-780-5500Provider last certified this registry record 5 Oct 2023.
Clinical trials
- Distribution of Medication Disposal Packets - Acute Opioid Prescribing
Sponsor: University of Pennsylvania
- FITBIT Study on Mobility and Readmissions After Radical Cystectomy
Sponsor: University of Pennsylvania
- IOP and Medication Reduction in MIGS Procedures
Sponsor: Wills Eye
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
54 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ARGENX US, INC.Program year202526 payments
- HARMONY BIOSCIENCES LLCProgram year202524 payments
- UCB, Inc.Program year202514 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
95.6%Other antiepileptics14.2%Levetiracetam50%Topiramate27%Lacosamide23%Part D<11 patientsGabapentinoids12.8%Gabapentin85%Pregabalin15%Part D<11 patients+ 18 more classes in this area
Cardiovascular
1.8%Beta blocker1.1%Propranolol Hcl Er100%Part D<11 patientsAdrenergic and dopaminergic agents0.7%Northera100%Part D<11 patientsMusculoskeletal
1.3%Central alpha-2 Adrenergic Agonist1.3%Tizanidine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- Arginine Sensor (CASTOR1) Dysfunction Drives Tauopathy
University of Kentucky
FY2026$423,500R21AG098743 - Emerging Role of Tau Citrullination During Alzheimer’s disease and Tauopathies
University of Kentucky
FY2025$491,581R01AG072728 - Emerging Role of Tau Citrullination During Alzheimer’s disease and Tauopathies
University of Kentucky
FY2024$533,219R01AG072728
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”